TNF and Alzheimer disease: Future studies should focus on the question what the neurotoxin secreted by A1s is, and on new drugs which are potential to treat various CNS diseases including AD by preventing A1 formation, promoting A1 reversion, or blocking the neurotoxin, and on whether available drugs approved to inhibit human IL-1α and TNF-α could be applied on AD.